SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
SION

Sionna Therapeutics, Inc. (NASDAQ:SION)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$2.83-$0.14 (-4.88%)
 
Market cap
$128M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 7, 2025
Market Cap$127.79M-93.6%
Revenue (ttm)$0
Net Income-$109.52M-55.0%
EPS-$2.44-52.2%
Shares Out45.24M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume547,657
Open$2.91
Previous Close$2.97
Day's Range$2.76 - $3.03
52-Week Range$2.75 - $54.97
Beta1.22
AnalystsHold
Price Target$27.40(+869.91%)
Earnings DateMar 1, 2027

About SION

Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a transmembrane domain 1 (TMD1)-directed cystic fibrosis transmembrane conductance regulator (CFTR) that has completed Phase 2 trial; navocaftor (SION-3067), a potentiator that has completed Phase 2 trial; SION-109, an intracellular loop 4 directed CFTR corrector that has completed Phase 1 trial; SION-2851, a TMD1-directed CFTR corrector that has completed Phase 1 trial; SION-451, which is nucleotide-binding domain 1 stabilizer in Phase 1 trial; and SION-719, which is nucleotide-binding domain 1 stabilizer in Phase 2a proof-of-concept trial. The company was formerly known as Sling Therapeutics, Inc. and changed its name to Sionna Therapeutics, Inc. in July 2021. Sionna Therapeutics, Inc. was incorporated in 2019 and is headquartered in Waltham, Massachusetts.

Address
21 Hickory Drive Suite 500, Waltham, MA, 02451, US
Market Cap
128 million
Employees
59
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$82.50M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Hold
0 Buy1 Hold0 SellAvg target $45.40 (+1507.1%)

1 firm rating SION in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From SION’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-4.88%
5 Days
-14.65%
1 Month
-25.66%
6 Months
-93.13%
1 Year
-93.63%

$SION stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in SION holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by SION's directors and management

Net Shares Purchased by Insiders−4M−2M02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

SION Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New SION patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to SION from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in SION

VTIVanguard Morningstar Total Stock Market ETF$2.85M
IWMiShares Russell 2000 ETF$1.41M
VXFVanguard Extended Market ETF$873.51K
IBBiShares Biotechnology ETF$581.66K
IWOiShares Russell 2000 Growth ETF$521.53K
VTWOVanguard Russell 2000 ETF$460.94K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from SION’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
20
Buy Value
$0
Distinct Buyers
0

Insider Score Trend Over Time

+0.0 since Sep 22
0255075100Sep 22 — Insider Score 0.0Sep 23 — Insider Score 0.0Sep 24 — Insider Score 0.0Sep 25 — Insider Score 0.0Sep 26 — Insider Score 0.0Sep 27 — Insider Score 0.0Sep 28 — Insider Score 0.0Sep 29 — Insider Score 0.0Sep 30 — Insider Score 0.0Oct 1 — Insider Score 0.0Oct 2 — Insider Score 24.0Oct 3 — Insider Score 0.0Oct 4 — Insider Score 0.0Sep 22Sep 28Oct 4

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

SBIOALPS Medical Breakthroughs ETF0.10%
BBCVirtus Biotech Clinical Trials ETF0.08%
PJSMPGIM Jennison Small-Mid Cap Core Equity ETF0.07%
IBBQInvesco Nasdaq Biotechnology ETF0.01%
IBBiShares Biotechnology ETF0.01%
BIBProShares Ultra Nasdaq Biotechnology0.01%
FSEGFidelity Enhanced Small Cap Growth ETF0.00%
VHTVanguard Health Care ETF0.00%
FHLCFidelity MSCI Health Care Index ETF0.00%

Weight is the stock’s share of each fund’s holdings.